TickerFacts.

PepGen Inc. (PEPG): Depreciation & Amortization

Annual figures by period end, from SEC filings.

$1.40M
Year ended 2025-12-31
$1.30M
Trailing 12 months to 2026-06-30
+40.9%
3-year compound annual growth
$1.50M2021-12-31: $200.0K2022-12-31: $500.0K2023-12-31: $1.20M2024-12-31: $1.50M2025-12-31: $1.40M$1.40M
2021-12-31 Depreciation & Amortization (USD) 2025-12-31
Period endedDepreciation & AmortizationChange YoYSource filing
2025-12-31$1.40M-6.7%2026-03-04, From 2025-01-01
2024-12-31$1.50M+25.0%2026-03-04, From 2024-01-01
2023-12-31$1.20M+140.0%2025-02-24, From 2023-01-01
2022-12-31$500.0K+150.0%2024-03-29, From 2022-01-01
2021-12-31$200.0Kn/a2023-03-23, From 2021-01-01

Depreciation & Amortization at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedDepreciation & AmortizationChange YoY
PepGen Inc. (PEPG)2025-12-31$1.40M-6.7%
Gossamer Bio, Inc. (GOSS)2025-12-31$24.0K-97.1%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)2025-12-31$233.0K-60.4%
Climb Bio, Inc. (CLYM)2025-12-31$97.0Kn/a
Gyre Therapeutics, Inc. (GYRE)2025-12-31$2.48M+60.2%
Benitec Biopharma Inc. (BNTC)2026-06-30$58.0K-12.1%
Alto Neuroscience, Inc. (ANRO)2024-12-31$502.0K+34.6%
Lexicon Pharmaceuticals, Inc. (LXRX)2025-12-31$621.0K+16.3%
Transcode Therapeutics, Inc. (RNAZ)2025-12-31$76.4K-15.9%

Compare PEPG, GOSS, CRBP, CLYM side by side · Screen every company in Pharmaceutical Preparations ↗